Akebia Therapeutics (AKBA) Inventory Average (2019 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Inventory Average of $14.3 million for Q1 2026, down 20.48% year-over-year from $18.0 million in Q1 2025, and down 16.49% quarter-over-quarter from $17.1 million in Q4 2025.
Akebia Therapeutics (AKBA) Inventory Average (2019 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Inventory Average for 8 consecutive years, with $14.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average fell 20.48% year-over-year to $14.3 million; the TTM figure through Mar 2026 stood at $14.3 million (down 20.48% YoY), while the FY2025 annual figure was $15.9 million, changed 0.25% from the prior year.
- Inventory Average slipped to $14.3 million in Q1 2026 per AKBA's latest filing, from $17.1 million in the prior quarter.
- Across five years, Inventory Average topped out at $42.7 million in Q3 2022 and bottomed at $14.3 million in Q1 2026.
- Historically, Inventory Average has averaged $23.8 million across 5 years, with a median of $20.6 million in 2024.
- Annual changes were most pronounced in 2023 — Inventory Average tumbled 53.96% — and 2024, when it grew 19.58%.
- Akebia Therapeutics' Inventory Average stood at $33.4 million in 2022, then sank by 48.91% to $17.1 million in 2023, then gained by 7.63% to $18.4 million in 2024, then slipped by 6.76% to $17.1 million in 2025, then dropped by 16.49% to $14.3 million in 2026.
- Business Quant data shows AKBA's Inventory Average at $14.3 million in Q1 2026, $17.1 million in Q4 2025, and $17.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | 13.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.01 Mn |
| Mar 31, 2026 | 14.30 Mn |
| Dec 31, 2025 | 17.13 Mn |
| Sep 30, 2025 | 17.68 Mn |
| Jun 30, 2025 | 18.22 Mn |
| Mar 31, 2025 | 17.99 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Sep 30, 2024 | 22.18 Mn |
| Jun 30, 2024 | 24.70 Mn |
| Mar 31, 2024 | 20.61 Mn |
| Dec 31, 2023 | 17.07 Mn |
| Sep 30, 2023 | 19.67 Mn |
| Jun 30, 2023 | 20.66 Mn |
| Mar 31, 2023 | 20.99 Mn |
| Dec 31, 2022 | 33.41 Mn |
| Sep 30, 2022 | 42.73 Mn |
| Jun 30, 2022 | 40.66 Mn |
| Mar 31, 2022 | 38.86 Mn |
| Dec 31, 2021 | 35.16 Mn |
| Sep 30, 2021 | 35.79 Mn |